Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Epogee is a food technology company that has developed EPG (Esterified Propoxylated Glycerol), a revolutionary fat alternative designed to significantly reduce calories without sacrificing the taste or texture of food. EPG is a modified plant-based oil that resists digestion by pancreatic lipase, allowing it to pass through the body with minimal caloric absorption. The technology is used in various food categories, including confectionery, snacks, and baked goods, to address the global health challenges of obesity and metabolic disease. Epogee's mission is to improve public health by providing a tool for effective calorie management in everyday foods. The company's EPG technology is Generally Recognized as Safe (GRAS) and is currently utilized by several commercial food brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Epogee.